Wednesday § July 1, 2009
Pharma Lobbying Targets Leading Democrats Ahead of Healthcare Reform Debate
The country’s largest drug lobby, PhRMA, spent $6.9 million during the first three months of this year on lobbying expenses, an almost 40 percent jump from what it spent on average per quarter last year. The biggest reason for all the new hires? Democrats. The lobby is particularly targeting Sen. Baucus — the leading reform figure and Sen. Kennedy alternative to a more conservative approach to Obama’s proposed healthcare reform package. Recall that PhRMA recently pledged $80M to the healthcare reform effort, with 2/3 going to fund, among other things, a so-called “reform fee”, which will charge pharma companies a fee to cover any difference between the cost of Medicare, Medicaid and biogenerics programs and the $80M spending commitment. Are PhRMA lobbyists trying to pre-empt efforts of some congressional Democrats’ attempts at industry price controls as part of the reform package? | LINK
Related Posts Within Doctor Pundit:
- Senator Touts Alliance by Pharma and AARP as Key Effort in Healthcare Reform The nation’s largest drug lobby, PhRMA, desperate to be included...
- As Debate on Healthcare Reform Nears, Players (and Stakes) Become Readily Apparent The closer we get to possible legislation mandating an increase...
- Drug Lobby Exposes White House Deal on Pharma Portion of Reform Bill The White House has another damage control problem on its...

